tricalcium phosphate has been researched along with Lung Diseases, Obstructive in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alvarez-Mon, M; Alvarez-Sala, JL; Alvarez-Sala, R; Bernstein, ED; Callol, L; de LUCAS, P; Izquierdo, JL; Martinez, B; Monserrat, J; Prieto, A; Reyes, E; Villarrubia, VG | 1 |
| Celdrán Gil, J; Durán Pérez-Navarro, A; Marcos Sánchez, F; Rodríguez Gallego, C | 1 |
1 trial(s) available for tricalcium phosphate and Lung Diseases, Obstructive
| Article | Year |
|---|---|
Defective natural killer and phagocytic activities in chronic obstructive pulmonary disease are restored by glycophosphopeptical (inmunoferón).
Topics: Adjuvants, Immunologic; Calcium Phosphates; Cytotoxicity, Immunologic; Double-Blind Method; Female; Glycopeptides; Humans; Killer Cells, Natural; Lung Diseases, Obstructive; Macrophages; Male; Middle Aged; Neutrophils; Phagocytosis | 2001 |
1 other study(ies) available for tricalcium phosphate and Lung Diseases, Obstructive
| Article | Year |
|---|---|
[The clinical evaluation of glycophosphopeptical (Immunoferon) as combined treatment in patients with chronic lung disease].
Topics: Aged; Calcium Phosphates; Drug Evaluation; Drug Therapy, Combination; Female; Glycopeptides; Humans; Lung Diseases, Obstructive; Male; Middle Aged | 1989 |